All In Biotech

Drug Trial Radar · NCT06637371

A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma

A Phase 1, Randomized, Double-blind, Placebo-controlled, Integrated Single Ascending Dose, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma

Last checked: Nov 20, 2026Latest source record: Oct 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

21

Actual

Start

Oct 16, 2024

Primary completion

Apr 10, 2027

Study completion Apr 10, 2027

Sponsor

Lead sponsor
AmgenAmgen (AMGN)
Sponsor type
Industry
First posted
Oct 15, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Sequential
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The main objective of this study is to assess the safety and tolerability of AMG 691 as single doses (healthy participants only) and multiple doses in healthy participants and participants with mild-to-moderate asthma.

Conditions

  • Asthma

Interventions

  • AMG 691Drug

    Subcutaneous (SC) injection

  • PlaceboDrug

    SC injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants Experiencing Treatment-emergent Adverse Events (TEAEs)Time frame: Up to approximately 11 months

Locations

21 sites in 5 countries. Site status is shown where the registry gives one.

  • Orange County Research Center

    Lake Forest, California

  • Translational Clinical Research LLC

    Aventura, Florida

  • Destiny Research Center

    Palmetto Bay, Florida

  • ClinCept, LLC

    Columbus, Georgia

  • Chesapeake Clinical Research Inc

    White Marsh, Maryland

  • Brigham and Womens Hospital

    Boston, Massachusetts

  • Mayflower Clinical

    South Dartmouth, Massachusetts

  • Mayo Clinic

    Rochester, Minnesota

  • Prism Research LLC dba Nucleus Network

    Saint Paul, Minnesota

  • University of North Carolina Clinical and Translational Research Center

    Chapel Hill, North Carolina

  • Monroe Biomedical Research

    Monroe, North Carolina

  • North Carolina Clinical Research

    Raleigh, North Carolina

  • Allergy Asthma and Clinical Research Center

    Oklahoma City, Oklahoma

  • Monroe Biomedical Research

    North Charleston, South Carolina

  • Endeavor Clinical Trials

    San Antonio, Texas

  • Clinical Medical and Analytical eXellence CMAX

    Adelaide, South Australia, Australia

  • Algemeen Ziekenhuis Sint Maarten-Emmaus vzw

    Mechelen, Belgium

  • Winchester District Memorial Hospital

    Winchester, Ontario, Canada

  • VPD Heart and Lung Research Institute

    Cambridge, United Kingdom

  • Chelsea and Westminster Hospital

    London, United Kingdom

  • The Medicines Evaluation Unit

    Manchester, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.